Importance: An altered sense of smell and taste has been reported to be associated with coronavirus disease 2019 (COVID-19). To understand the evolution of these symptoms during the course of the disease is important to identify patients with persistent loss of smell or taste and estimate the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the burden of olfactory and gustative dysfunctions.
Objective: To evaluate the evolution of the loss of sense of smell and taste in a case series of mildly symptomatic patients with SARS-CoV-2 infection.
Design, Setting, And Participants: This cross-sectional survey-based study included 202 mildly symptomatic adults (≥18 years) consecutively assessed at Treviso Regional Hospital, Italy, between March 19 and March 22, 2020, who tested positive for SARS-CoV-2 RNA by polymerase chain reaction on nasopharyngeal and throat swabs.
Main Outcomes And Measures: Prevalence of altered sense of smell and taste at follow-up and their variation from baseline.
Results: Of 202 patients completing the survey at baseline, 187 (92.6%) also completed the follow-up survey (103 [55.1%] women; median age, 56 years). The evaluation of the evolution of altered sense of smell or taste in the 113 patients reporting sudden onset of these symptoms at baseline showed that 55 patients (48.7%; 95% CI, 39.2-58.3) reported complete resolution of smell or taste impairment, 46 (40.7%; 95% CI, 31.6-50.4) reported an improvement in the severity, and only 12 (10.6%; 95% CI, 5.6-17.8) reported the symptom was unchanged or worse. Persistent loss of smell or taste was not associated with persistent SARS-CoV-2 infection.
Conclusions And Relevance: At 4 weeks from the onset, 89% of the SARS-CoV-2-positive mildly symptomatic patients who had had a sudden onset of altered sense of smell or taste experienced a complete resolution or improvement of these symptoms. Persistent loss of smell or taste was not associated with persistent SARS-CoV-2 infection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333173 | PMC |
| http://dx.doi.org/10.1001/jamaoto.2020.1379 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Liver Enzymes and Inflammatory Markers Among Severely Ill COVID-19 Patients: A Retrospective Case-Control Study in Telangana.
Cureus
December 2024
Biochemistry, RVM Institute of Medical Sciences and Research Center, Hyderabad, IND.
Article Synopsis
- The COVID-19 pandemic, which began in Wuhan, has notably impacted the respiratory system, but it also affects other organs like the liver, making it one of the deadliest infectious diseases recently.
- This study compared liver function and inflammation in 200 hospitalized COVID-19 patients to a matched group of healthy controls, revealing that a high number of patients had elevated liver enzymes and inflammatory markers.
- The findings suggest a significant relationship between COVID-19 and liver health, indicating the need for further research and regular liver function tests for infected patients to guide treatment and monitor their condition.
Reconceptualizing Disorders of the Self as Disorders of Relationship.
Arch Phys Med Rehabil
January 2025
Objective: To validate a universal neuropsychological model that suggests that disorders of the self are best conceptualized as disintegrated neuropsychological processes (i.e., sensations, mental experiences) that lack a sense of relationship to the unified experience/sense of self.
View Article and Find Full Text PDFRoles of sensory receptors in non-sensory organs: the kidney and beyond.
Nat Rev Nephrol
January 2025
Department of Physiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Olfactory receptors (ORs), taste receptors and opsins are well-known for their pivotal roles in mediating the senses of smell, taste and sight, respectively. However, in the past two decades, research has shown that these sensory receptors also regulate physiological processes in a variety of non-sensory tissues. Although ORs, taste receptors and opsins have all been shown to have physiological roles beyond their traditional locations, most work in the kidney has focused on ORs.
View Article and Find Full Text PDFPotential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity.
PLoS One
January 2025
Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
Article Synopsis
- Analyzed associations of lab parameters, symptoms, and 12 genetic SNPs with COVID-19 severity in 869 hospitalized patients.
- Confirmed links between pre-existing diabetes and COVID-19 severity, and found a surprising connection between milder cases and loss of smell/taste.
- Identified specific genetic variants (LZTFL1, IFNAR2) associated with increased susceptibility and severity of COVID-19, suggesting that genetics may help predict clinical outcomes alongside other factors.
Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis.
Mult Scler
January 2025
Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Background: Many common symptoms in post-acute sequelae following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) overlap with those of multiple sclerosis (MS). We examined symptoms and performance of the PASC score, developed in the general population, in MS based on infection history.
Methods: We surveyed North American Research Committee on Multiple Sclerosis (NARCOMS) registry participants regarding infections and categorized participants based on infection history.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!